Related Experiment Video
Updated: Mar 15, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
14.8K
Treatment resistant depression or dementia: a case report
Zhongyong Shi1, Shifu Xiao2, Xia Li2
1Shanghai Tenth People's Hospital, Shanghai Tong Ji University, Shanghai, China ; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Archives of Psychiatry
|September 9, 2016
Summary
Diagnosing elderly patients with both depression and dementia symptoms is challenging. Long-term follow-up is crucial to differentiate between these conditions and guide treatment.
Area of Science:
- Geriatric Psychiatry
- Neuropsychology
- Internal Medicine
Background:
- Distinguishing between depression and dementia in older adults presents diagnostic challenges.
- This case highlights the complexity of co-occurring depressive and cognitive symptoms in the elderly.
Observation:
- A 78-year-old female with a history of major depression presented with concurrent depressive and dementia-like symptoms.
- Initial clinical and neuropsychiatric evaluations were insufficient for definitive diagnosis.
- Treatment involving medication adjustment, psychotherapy, and antihypertensive changes improved mood but not cognition.
Findings:
- Cognitive symptoms persisted despite 8 weeks of inpatient treatment and 7 months of follow-up.
- Subsequent worsening of depressive and cognitive symptoms coincided with advanced breast cancer and chemotherapy.
- A definitive diagnosis distinguishing between depression-related cognitive impairment and dementia requires 2-3 years of longitudinal assessment.
Implications:
- Accurate diagnosis in elderly patients with overlapping depression and dementia symptoms requires extended observation.
- Treatment response is a critical factor in differentiating between these conditions.
- This case underscores the need for a nuanced, long-term approach to geriatric neuropsychiatric disorders.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:30Dementia
658
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
658
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:05Long-term Depression
33.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.6K
01:03Long-term Depression
3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.5K
01:26Psychosis: Goals of Pharmacotherapy
651
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
651